Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Biosimilars are gaining ground. The IRA could push them even further next year.
Pharma Voice
Mon, 05/13/24 - 11:21 am
biosimilars
Inflation Reduction Act
drug pricing
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters
Wed, 05/8/24 - 10:58 pm
Teva Pharmaceutical
earnings
biosimilars
AbbVie
Humira
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Sandoz
earnings
biosimilars
AbbVie
Humira
FDA Approval Fuels Boehringer’s Biosimilar Challenge to AbbVie’s Humira
BioSpace
Thu, 05/2/24 - 11:37 am
Boehringer Ingelheim
Cyltezo
AbbVie
Huira
FDA
biosimilars
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
CVS Caremark
AbbVie
Humira
biosimilars
Hyrimoz
Sandoz
PBMs
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters
Sun, 04/28/24 - 11:18 pm
AbbVie
Humira
PBMs
biosimilars
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
BioSpace
Fri, 04/26/24 - 11:09 am
Cigna
Evernorth Health
Accredo
AbbVie
Humira
biosimilars
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
BioSpace
Fri, 04/19/24 - 11:28 am
Alvotech
Teva Pharmaceutical
Humira
AbbVie
Simlandi
biosimilars
Humira biosimilar scripts take off
Axios
Tue, 04/16/24 - 07:42 am
AbbVie
Humira
biosimilars
CVS Health
Removing the Misconceptions Surrounding Biosimilar Interchangeability
Center for Biosimilars
Tue, 04/16/24 - 07:41 am
FDA
interchangeability
biosimilars
Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future
Pharma Voice
Tue, 04/9/24 - 05:45 pm
biosimilars
Biocon
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report
BioSpace
Tue, 04/9/24 - 11:15 am
AbbVie
Humira
biosimilars
Boehringer to lay off salespeople as Humira biosimilar sales lag
Reuters
Fri, 04/5/24 - 11:33 am
Boehringer Ingelheim
AbbVie
Humira
biosimilars
layoffs
Teva, forging ahead with new strategy, inks biosimilar deal with Spain's mAbxience
Fierce Pharma
Thu, 04/4/24 - 11:16 am
Teva Pharmaceutical
Spain
mAbxience
oncology
biosimilars
Drugmaker seeks approval for China's first biosimilar Ozempic
Reuters
Wed, 04/3/24 - 11:07 am
Novo Nordisk
Ozempic
China
biosimilars
Hangzhou Jiuyuan Gene Engineering
Biden plan would axe interchangeable status for biosimilars
Pharmaphorum
Wed, 03/13/24 - 10:38 am
Joe Biden
biosimilars
interchangeability
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Fresenius Kabi
FDA
biosimilars
Actemra
Tyenne
Genentech
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US
Fierce Pharma
Thu, 02/29/24 - 06:57 pm
JNJ
Stelara
biosimilars
Biocon Biologics
Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster
First Word Pharma
Thu, 02/22/24 - 11:43 am
Samsung Bioepis
Merck
biosimilars
Keytruda
clinical trials
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »